Eastwood Bio-Medical Canada Inc (EBM) — Strategic Asset Allocation Index
Eastwood Bio-Medical Canada Inc (EBM) has a Strategic Asset Allocation Index of 1604.2% as of April 2021. Strategic assets (PP&E of CA$597.08K plus long-term investments of CA$-) total CA$597.08K, measured against net assets of CA$37.22K. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Eastwood Bio-Medical Canada Inc Strategic Asset Allocation Index (2018–2020)
This chart shows how Eastwood Bio-Medical Canada Inc's Strategic Asset Allocation Index has evolved across 3 annual periods from 2018 to 2020. As of April 2021, the index stands at 1604.2%, representing strategic assets of CA$597.08K against net assets of CA$37.22K CAD. Explore cash flow conversion of Eastwood Bio-Medical Canada Inc to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Eastwood Bio-Medical Canada Inc (2018–2020)
The table below presents the year-by-year Strategic Asset Allocation Index for Eastwood Bio-Medical Canada Inc from 2018 to 2020, covering 3 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see EBM market cap.
| Year | SAAI | Strategic Assets (CAD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2020 | 141.4% | CA$649.58K | CA$649.58K | CA$- | CA$459.27K | ▲ +106.6 pp |
| 2019 | 34.8% | CA$456.60K | CA$456.60K | CA$- | CA$1.31 Million | ▲ +20.9 pp |
| 2018 | 13.9% | CA$262.59K | CA$262.59K | CA$- | CA$1.89 Million | — |